These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
695 related items for PubMed ID: 16626889
1. FDG-PET/CT in the evaluation of anal carcinoma. Cotter SE, Grigsby PW, Siegel BA, Dehdashti F, Malyapa RS, Fleshman JW, Birnbaum EH, Wang X, Abbey E, Tan B, Kodner IJ, Hunt SR, Lowney JK, Mutch MG, Dietz DW, Myerson RJ. Int J Radiat Oncol Biol Phys; 2006 Jul 01; 65(3):720-5. PubMed ID: 16626889 [Abstract] [Full Text] [Related]
2. Contrast-enhanced [(18)F]fluorodeoxyglucose-positron emission tomography/computed tomography for staging and radiotherapy planning in patients with anal cancer. Bannas P, Weber C, Adam G, Frenzel T, Derlin T, Mester J, Klutmann S. Int J Radiat Oncol Biol Phys; 2011 Oct 01; 81(2):445-51. PubMed ID: 20832181 [Abstract] [Full Text] [Related]
3. Role of positron emission tomography-computed tomography in the management of anal cancer. Mistrangelo M, Pelosi E, Bellò M, Ricardi U, Milanesi E, Cassoni P, Baccega M, Filippini C, Racca P, Lesca A, Munoz FH, Fora G, Skanjeti A, Cravero F, Morino M. Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):66-72. PubMed ID: 22592047 [Abstract] [Full Text] [Related]
4. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer. Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y. Acta Radiol; 2009 Jul 01; 50(6):638-44. PubMed ID: 19492198 [Abstract] [Full Text] [Related]
5. Comparison of positron emission tomography scanning and sentinel node biopsy in the detection of inguinal node metastases in patients with anal cancer. Mistrangelo M, Pelosi E, Bellò M, Castellano I, Cassoni P, Ricardi U, Munoz F, Racca P, Contu V, Beltramo G, Morino M, Mussa A. Int J Radiat Oncol Biol Phys; 2010 May 01; 77(1):73-8. PubMed ID: 19632066 [Abstract] [Full Text] [Related]
6. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer. Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y. Acta Radiol; 2010 Mar 01; 51(2):150-5. PubMed ID: 20092375 [Abstract] [Full Text] [Related]
7. Prognostic value of fluorodeoxyglucose positron emission tomography/computed tomography and inguinal sentinel lymph node biopsy in patients with anal cancer. De Nardi P, Guarneri G, Canevari C, Tamburini A, Slim N, Passoni P, Rosati R. Colorectal Dis; 2019 Sep 01; 21(9):1017-1024. PubMed ID: 31077550 [Abstract] [Full Text] [Related]
8. Clinical relevance of positron emission tomography/computed tomography-positive inguinal nodes in rectal cancer after neoadjuvant chemoradiation. Perez RO, Habr-Gama A, São Julião GP, Proscurshim I, Ono CR, Lynn P, Bailão Aguilar P, Nahas SC, Gama-Rodrigues J, Buchpiguel CA. Colorectal Dis; 2013 Jun 01; 15(6):674-82. PubMed ID: 23374979 [Abstract] [Full Text] [Related]
9. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer? Schaefferkoetter JD, Carlson ER, Heidel RE. J Oral Maxillofac Surg; 2015 Jul 01; 73(7):1420-8. PubMed ID: 25869746 [Abstract] [Full Text] [Related]
10. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer. Sasaki K, Kawasaki H, Sato M, Koyama K, Yoshimi F, Nagai H. Dig Surg; 2017 Jul 01; 34(1):60-67. PubMed ID: 27454870 [Abstract] [Full Text] [Related]
11. Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. Grigsby PW, Siegel BA, Dehdashti F. J Clin Oncol; 2001 Sep 01; 19(17):3745-9. PubMed ID: 11533097 [Abstract] [Full Text] [Related]
12. Can the radiation dose to CT-enlarged but FDG-PET-negative inguinal lymph nodes in anal cancer be reduced? Mai SK, Welzel G, Hermann B, Wenz F, Haberkorn U, Dinter DJ. Strahlenther Onkol; 2009 Apr 01; 185(4):254-9. PubMed ID: 19370429 [Abstract] [Full Text] [Related]
13. Lymph node staging of gastric cancer using (18)F-FDG PET: a comparison study with CT. Yun M, Lim JS, Noh SH, Hyung WJ, Cheong JH, Bong JK, Cho A, Lee JD. J Nucl Med; 2005 Oct 01; 46(10):1582-8. PubMed ID: 16204706 [Abstract] [Full Text] [Related]
14. Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH. Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1506-12. PubMed ID: 15050330 [Abstract] [Full Text] [Related]
15. Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography/computed tomography in staging clinically node-negative patients with penile carcinoma. Leijte JA, Graafland NM, Valdés Olmos RA, van Boven HH, Hoefnagel CA, Horenblas S. BJU Int; 2009 Sep 01; 104(5):640-4. PubMed ID: 19281465 [Abstract] [Full Text] [Related]
16. Positron emission tomography/computed tomography in the staging and treatment of anal cancer. Sveistrup J, Loft A, Berthelsen AK, Henriksen BM, Nielsen MB, Engelholm SA. Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):134-41. PubMed ID: 22000745 [Abstract] [Full Text] [Related]